Debiopharm is advancing its ADC platform with a focus on proprietary bispecific ADCs and innovative payloads. By leveraging its proven drug development expertise, the company aims to accelerate ...

One of the oldest challenges in oncology is creating a drug that kills cancer cells while sparing healthy ones. Peptides are ...

The Doodle shows how the parabola changes with different numbers, making learning math fun and interactive for students.,, ...

MONTREAL, Nov. 13, 2025 /CNW/ – Myeloma Canada welcomes the Canadian Drug Agency’s (CDA) two positive recommendations for the ...

Q3 2025 Earnings Call Transcript November 10, 2025 ADC Therapeutics S.A. beats earnings expectations. Reported EPS is ...

We applied swim flume-mediated exercise during zebrafish caudal fin regeneration to explore mechanical loading impacts on a robust model of organ regeneration. Exercise initiated during but not after ...

Good morning, everyone, and welcome, everyone, to the Prelude Therapeutics Investor Conference Call. Today's call is being recorded and is expected to last up to 45 minutes. At this time, I will now ...

"I just liked working with them so much that I joined them," Chen told BioWorld. Today, Chen is co-CEO of WuXi AppTec. The company, which started with a laboratory of 7,000 square feet, has grown into ...